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Abstract
Objective To study the association between consumption
of dairy products and calcium intake and risk of breast
cancer risk according to menopausal status.
Methods In a population-based prospective cohort study
of 64,904 Norwegian women followed from 1996/1999
through 2006, we examined total dairy consumption and
consumption of various dairy products in relation to pre-
and postmenopausal breast cancer risk. We also examined
breast cancer in relation to calcium intake and to milk
consumption during childhood and performed additional
analyses corrected for measurement errors in the dietary
data. In total, 218 premenopausal and 1,189 postmeno-
pausal incident breast cancer cases were diagnosed during
follow-up.
Results Total dairy, adult, and childhood milk consump-
tion was not associated with either pre- or postmenopausal
breast cancer risk. Premenopausal women with the highest
consumption of white cheese had half the risk of breast
cancer compared to those with the lowest consumption
(hazard rate ratio in the 4th quartile vs. the 1st quartile
0.50, 95% conﬁdence interval 0.29–0.87). Total calcium
intake tended to be inversely related to premenopausal
(hazard rate ratio in the 4th quartile vs. the 1st quartile
0.65, 95% conﬁdence interval 0.39–1.08) and postmeno-
pausal breast cancer (hazard rate ratio in the 4th quartile vs.
the 1st quartile 0.85, 95% conﬁdence interval 0.70–1.04).
Correcting for measurement errors did not alter the results
substantially, nor did exclusion of early cancer cases.
Conclusion Dairy consumption is not strongly related to
breastcancerriskinthisprospectivestudy.Anon-signiﬁcant
negative association between calcium intake and breast
cancer risk was seen, particularly among premenopausal
women.
Keywords Milk  Calcium  Food frequency
questionnaire  Measurement errors  Norway
Introduction
A high consumption of dairy products is common in many
Western populations [1]. The food group often contributes
a substantial part of individual’s intake of saturated fat and
calcium, and also vitamin D in areas with widespread
vitamin D fortiﬁcation of dairy products. Whereas satu-
rated fat has been suggested to increase the risk of breast
cancer [2], calcium and vitamin D—whether supplied
through the diet or synthesized in the skin during sun
exposure—have been hypothesized to decrease the risk [3].
Also other components of dairy products have been pro-
posed to inﬂuence the risk of breast cancer, e.g., an
increased risk by environmental contaminants and insulin-
like growth factors [4–6], and a decreased risk by conju-
gated linoleic acids [7, 8]. The fact that dairy products
contain a mixture of components that possibly inﬂuences
breast cancer risk in opposite directions makes the net
effect of dairy consumption difﬁcult to settle.
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analysis [9] and a pooled analysis of cohort studies [10]
have concluded that there is no evidence for a strong
association between dairy consumption and breast cancer
risk. Positive [11], negative [12–14], and null ﬁndings [15–
20] have been reported in cohort studies. Moreover, the
ﬁndings may vary according to menopausal status [21–23]
and between various dairy products [11, 12, 15]. Also for
calcium intake the association with breast cancer is
inconsistent and may differ with menopausal status [3, 20,
21, 23, 24].
In an earlier study of premenopausal breast cancer in the
Norwegian Women and Cancer study (NOWAC), we
found an inverse association between milk consumption
and breast cancer risk [25]. The age-adjusted incidence rate
of breast cancer in Norway is high (72.8 per 100,000
person-years in 2008) [26] and so is the consumption of
milk and other dairy products (per capita supply in 2008
was 178 kg) [27]. In the present study, we wanted to
examine breast cancer risk and dairy consumption more
thoroughly using more detailed dietary data from NOWAC
(comprising intake of several dairy products and calcium),
a higher number of breast cancer cases, and performing
analyses for both pre- and postmenopausal women. Fur-
thermore, as dietary data are prone to measurement errors
we also perform corrections for such errors in our risk
analyses by applying validation data from a sub-sample of
NOWAC [28].
Materials and methods
Subjects and study design
NOWAC is a nationwide cohort study set up at the Uni-
versity of Tromsø, Norway in 1991. It currently comprises
more than 165,700 women born 1927–65 randomly drawn
from the National Central Person Register [29, 30]. There
is a small oversampling from the three most northern
counties (n = 13,674). Due to practical workload, ﬁnancial
restraints and methodological sub-studies [31] the baseline
enrollment was separated into a number of different sub-
series and carried out from 1991 to 1997, and from 2003 to
2006. As the follow-up time for the women in the last
inclusion period is very short, only women enrolled from
1991 to 1997 are included in the current paper. The women
received a mailed letter of invitation requesting informed
consent and a self-instructive questionnaire focusing on
certain topics (e.g., diet or sun exposure), and also con-
taining a number of core questions. Detailed dietary
questions have been included in the questionnaires since
1996. To expand and update the exposure information, a
second questionnaire was from 1998 to 2002 sent to the
responders of the baseline mailing conducted in 1991–1997.
After one or two reminders, the response rate for the ﬁrst
(baseline) questionnaire (1991–1997) was 57% (102,540/
179,387), and 81% (80,835/99,541) for the second ques-
tionnaire (1998–2002). The present analyses are restricted
to women who gave detailed dietary information in the
period 1996–1999, either in their ﬁrst questionnaire
(n = 30,333) or in their second questionnaire (n = 38,184).
The Regional Committee for Medical Research Ethics and
the Norwegian Data Inspection Board approved the study.
Dietary assessment and nutrient calculations
Dietary information was collected by means of a semi-
quantitative food frequency section in the questionnaire,
described in details previously [28, 32]. In short, the par-
ticipants were asked to record their average consumption of
various food items during the last year ticking off ﬁxed
boxes. Consumption of the following dairy items was
asked for: glasses of whole milk, low-fat milk and skim-
med milk drunk per week or day, packages of yoghurt
eaten per week or day, slices of bread with whole fat brown
cheese, low-fat/skimmed brown cheese, whole fat white
cheese and low-fat/skimmed white cheese eaten per week,
and frequency and amount of ice cream eaten per month or
week during the summer and during the rest of the year. In
addition, the participants were asked to record what kind of
fat (butter or margarine) they usually used on bread, and
how often and how much melted or solid fat, full fat sour
cream, and fat-reduced sour cream they used for ﬁsh meals.
Number of glasses of milk consumed per day during
childhood was recorded in most of the sub-series. Alcohol
intake was calculated from three questions on beer, wine,
and spirit consumption.
Daily intake of foods, energy and nutrients was com-
puted using a computation program developed at the
Institute of Community Medicine, University of Tromsø,
for SAS software. Missing frequencies were treated as null
intake and missing portion sizes as the smallest portion unit
in the questionnaire, giving a conservative intake estimate
[33]. For the women included in the analytic cohort, mode
for missing frequencies on the 10 relevant dairy questions
was zero; the median was two. The recorded frequency was
multiplied with the recorded portion size or a standard
portion [34], and transformed into daily food intake in
grams. Total dairy consumption was calculated by sum-
ming up the consumption of all the items listed above
(Table 1), except brown cheese and fat on bread and for
ﬁsh meals due to the dissimilar nutrient content of these
items. Nutrient intake was calculated by multiplying the
daily food intake (in grams) of each item with the nutrient
content of the item as given in the ofﬁcial Norwegian food
composition table [35]. Calcium intake was calculated
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tions), excluding supplements. Vitamin D intake was cal-
culated from all food items in the questionnaire including
cod liver oil (commonly used in Norway), but no other
supplements. At the time of the data collection, margarine
and butter were the only foods in Norway fortiﬁed with
vitamin D.
The intake of dairy foods and calcium was energy-
adjusted by using the residual method [36]. That is, we
added the residuals of the regression of the intake of dairy
foods and calcium on total energy intake, to the predicted
intake at mean level of energy intake.
Reproducibility and validity of the food frequency
questionnaire
The reproducibility of the questionnaire has been examined
in a sub-sample of 1,370 NOWAC participants [37].
Spearman’s correlation coefﬁcient between consumption of
milk, yoghurt and cheese in the test (February/March 2002)
and in the retest (May/June 2002) questionnaire was 0.74.
The relative validity of the questionnaire has been evaluated
against four repeated 24-h dietary recalls in a sub-sample of
238 NOWAC women [28].Comparedtothe registrations by
the 24-h recalls, the questionnaire slightly underestimated
theconsumptionofmilkandyoghurt,whereasnosigniﬁcant
differences were seen for consumption of cheese and ice
cream. Spearman’s correlation coefﬁcient between con-
sumption registered by the questionnaire and by the 24-h
recalls was 0.74 (95% conﬁdence intervals (CI) 0.68–0.79)
for milk and yoghurt, 0.42 (95% CI 0.31–0.52) for cheese
and 0.35 (95% CI 0.23–0.46) for ice cream. As for calcium,
the questionnaire underestimated the intake compared to the
24-h recalls (619 vs. 724 mg/day), Spearman’s correlation
coefﬁcient between the registrations made by the two
methods was 0.50 (95% CI 0.39–0.59), 68% of the subjects
were classiﬁed into the same or adjacent calcium quintile by
the two methods, and 2% were classiﬁed in the extreme
quintile. Parts of the questionnaire have also been evaluated
against fatty acid composition in serum phospholipids [32].
Assessment of other exposures
Information on age at invitation was obtained from
National Central Person Register. To handle the effect of
potential confounding factors and effect modifying factors
the following information was derived from the question-
naire: body weight and height, weight change since age 18,
level of physical activity, smoking status, years of educa-
tion, maternal history of breast cancer, mammography
practice, age at menarche, number of children and age at
ﬁrst birth, use of oral contraceptives, menopausal status,
and use of hormone replacement therapy (HRT) if
postmenopausal.
As only one single recording of menopausal status was
available for the present analyses, we assigned all women
who were premenopausal when ﬁlling out the questionnaire
to be postmenopausal when they reached the age of 50
during follow-up. This procedure was followed for women
reporting hysterectomy, whereas women reporting bilateral
oophorectomy were considered postmenopausal through-
out. The age of 50 as a dividing line for menopausal status
was chosen based on data from an older sub-sample of
NOWAC [38]. Information on self-reported menopausal
status and use of HRT has be evaluated against plasma
levels of sex hormones and found valid [39].
When checking for interactions between menopausal
status and dairy consumption, we examined both the effect
of menopausal status at the time of data recording and the
effect of menopausal status at end of follow-up. No sig-
niﬁcant interaction was seen in either of the analyses.
Identiﬁcation of breast cancer cases
Information from the questionnaire was linked to the
Cancer Registry of Norway to identify incident breast
cancer cases. In Norway, it is mandatory by law to report
all incident cancer cases to the cancer registry, and the
registry has an almost complete record of all cancer cases
[40–42]. More than 98% of the breast cancers were histo-
logically veriﬁed. In situ breast cancers were not regarded
as breast cancer. A corresponding linkage to records at
Statistics Norway provided information on death and
emigration. All linkages were done by means of the unique
individual national identiﬁcation number present in the
cohort data set and in the national registers, and ensured
complete follow-up.
Table 1 Consumption of dairy products (g/day) in the Norwegian
Women and Cancer study (n = 64,904)
Food item Median
(mean)
Total dairy 174 (220)
Whole milk 0 (15)
Low-fat milk 0 (81)
Skimmed milk 0 (68)
Yoghurt 12 (25)
Full fat white cheese 6 (13)
Low-fat/skimmed white cheese 0 (8)
Ice cream 4 (7)
Full fat sour cream (for ﬁsh) 0 (0.4)
Fat-reduced sour cream (for ﬁsh) 1 (2)
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Of the 68,517 women initially in the present cohort, we
excluded 2,900 women with a prior cancer diagnosis (any
type), one woman with uncertain breast cancer diagnosis,
seven women who died and three women who emigrated
before the start of the follow-up. We also excluded 104
women who did not answer any of the dairy questions, 585
women for whom the calculated daily energy intake was
below 2,500 kJ (n = 516) or above 15,000 kJ (n = 69),
and 13 women with implausible age at menopause. Thus,
64,904 women were included in the main analyses. In
addition, we performed analyses excluding women who
were diagnosed with any kind of cancer (n = 364) or died
(n = 41) during the ﬁrst year of follow-up in order to avoid
the possibility that undiagnosed cancer or other severe
illness inﬂuenced the self-reported data.
Statistical analyses
Person-years of follow-up were calculated as the time
elapsed from the date of the returned questionnaire (deﬁned
as 3 months after mailing of the invitation letter) to the
time of cancer (any type), to time of death or emigration, or
to the end of follow-up (31 December 2006), whichever
occurred ﬁrst. Cox proportional hazards regression analy-
ses were carried out to investigate the simultaneous effect
of dairy consumption and covariates on breast cancer
incidence rate, and hazard rate ratios (HRR) and 95% CI
were calculated.
Various categorizations (e.g., quartiles, users–non-users)
were applied for the dairy variables. The combined effect
of childhood milk consumption and adult dairy consump-
tion was examined by constructing a three-level variable:
‘low consumption,’ deﬁned as no milk consumption as a
child or 1st quartile of dairy consumption as adult and not
more than next-lowest consumption (1–3 glasses/day)/2nd
quartile on the other occasion; ‘high consumption,’ deﬁned
as the highest milk consumption as a child (7 or more
glasses/day) or 4th quartile of dairy consumption as adult
and not less than the next-highest consumption (4–6 glas-
ses/day)/3rd quartile on the other occasions; and ‘moderate
consumption,’ deﬁned as all other combinations. The low
consumption group was used as the reference category.
Calcium intake was examined in quartiles.
Different combinations of the covariates reported at
cohort enrollment were employed in multivariable analy-
ses: age at cohort enrollment (5-year categories), height
(quartiles:\163, 163–165, 166–169,[169 cm), body mass
index (BMI = (wt(kg))/(ht(m)
2)) (quartiles:\22.0, 22.0–23.9,
24.0–26.4, [26.4), BMI at age 18 (quartiles: \19.2,
19.2–20.5, 20.6–22.2, [22.2), weight increase since age
18 years (quartiles: \4, 4–9, 10–15, [15 kg), level of
physical activity (inactive, moderately active, active),
smoking status (current, former, never), education (\11,
11–13,[13 years), maternal history of breast cancer (yes,
no), mammography practice (no, every 2nd year or more
often, every 2nd year or more seldom), age at menarche
(quartiles:\13, 13, 14,[14 years), number of children and
ageatﬁrstbirth(nulliparous,1child/birthbeforeage21,2or
morechildren/ﬁrstbirthbeforeage21,1child/birthatage21
orolder,2ormore children/ﬁrstbirthatage21 orolder), use
of oral contraceptives (ever, never), and alcohol consump-
tion (0 and tertiles: 0.1–1.52, 1.53–4.13,[4.13 g/day). To
assess the inﬂuence of HRT (ever, never), we conducted
analysis restricted to women who were postmenopausal
when completing the questionnaire. Further, we examined
anypossibleconfoundingeffectofintakeoffruit,vegetables
and potatoes, fat, and vitamin D (all in quartiles). To adjust
for energy intake, we categorized the women according to
their energy-adjusted intake of each dairy variable (except
childhood milk consumption and the combined child/adult
consumption variable) and also added total energy intake
(in quartiles) to the model.
To test for linear trend in risk, we created a continuous
variable by assigning ordinal numbers to each level of
exposure and including the continuous variable in the
regression models.
Interaction effects were tested using the likelihood ratio
test. The assumptions of proportional hazards for the
exposures of interest were examined by log–log plots and
cumulative hazard plots.
To get an idea about the effect of measurement error in
the dietary data, we used the 24-h dietary recalls from the
validation study to perform a measurement error correction
based on the regression calibration method [43, 44]. Using
the energy-adjusted dairy variables and alcohol on its
original continuous scale, we constructed multivariate
calibration models by regressing the individual means of
the recall values of the dairy variables and alcohol on the
questionnaire values. Information about total energy
intake, age, height, weight increase since age 18, level of
physical activity, years of education, maternal history of
breast cancer, mammography practice, and use of oral
contraceptives were also included in this model. This was
done separately for each of the six dairy exposure vari-
ables. The calibration models are slightly smaller than the
full models used in the main analyses due to the lower
number of women included in the calibration. We excluded
variables assumed not to be associated with intake of dairy
products or alcohol. Data from 180 women were included
in the calibration. This is a somewhat lower number than
what was originally included in the validation study
(n = 238). The 180 women included here are those
among the 238 who are also included in the main analysis,
so that we were able to collect background information to
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SAS-macro blinplus (http://www.hsph.harvard.edu/faculty/
spiegelman/blinplus.html), we then performed a measure-
ment error correction based on this calibration model.
All reported p values are two-sided, and a signiﬁcance
criterion of p\0.05 was used to consider an association as
statistically signiﬁcant. The number of subjects included in
the separate analyses varies somewhat due to item non-
response. Statistical analyses were done by means of the
SAS software package, version 9.1.
Results
During 557,753 person-years of follow-up (average
8.6 years), 1,407 of the 64,904 women were diagnosed
with breast cancer. Two hundred eighteen of the diagnosed
breast cancers were regarded as premenopausal cancer, and
1,189 were regarded as postmenopausal cancer. The mean
age at diagnosis was 56.8 years (range 41.1–78.9).
Median daily consumption of dairy products was 174 g,
with low-fat milk and skimmed milk as the largest con-
tributors (Table 1). Less than 0.5% of the women did not
consume any dairy products at all.
Some characteristics of the cohort according to total
dairy consumption are given in Table 2. Most of the known
breast cancer risk factors did not vary noticeably across
quartiles of dairy consumption. Women in the 3rd quartile
of dairy consumption (174–369 g/day) tended to have more
years of education and a smaller fraction of them were
smokers compared to women in the other quartiles. Both
energy intake and daily intake of fat, calcium and vitamin
D increased with increasing intake of dairy products. Dairy
products were not fortiﬁed with vitamin D in Norway at the
time of data collection, and the positive association
between intake of vitamin D and dairy consumption can
largely be ascribed to a higher proportion taking cod liver
oil, an item very rich in vitamin D, in the higher quartiles.
The majority of the women (64%) reported drinking 1–3
glasses of milk per day during childhood, 27% reported
drinking 4–6 glasses per day and nearly 2% reported
drinking 7 glasses or more. Some 6% did not drink milk as
a child. Both total dairy consumption and total milk con-
sumption as an adult increased by increasing milk con-
sumption as a child (both: p for trend\0.001) (data not
shown). For instance, women who reported drinking 7 or
more glasses of milk as a child had an adult median daily
intake of milk of 150 g compared to 118 g for women who
Table 2 Characteristics
according to total dairy
consumption (g/day) in the
Norwegian Women and Cancer
study (n = 64,904)
At the time of ﬁlling in the
questionnaire
Characteristics Total dairy consumption (g/day)
1st quartile
(\92)
2nd quartile
(92–173)
3rd quartile
(174–369)
4th quartile
(C370)
Age, years (mean) 50.5 51.0 51.3 51.3
Height, cm (mean) 166 166 166 166
Body mass index, kg/m
2 (mean) 24.6 24.7 24.5 24.6
Weight increase since age 18 years, kg (mean) 10.4 10.3 9.9 10.1
Physical activity score (min 1–max 10, mean) 5.3 5.4 5.6 5.5
Current smokers (%) 35.4 32.1 25.7 33.8
Education, years (mean) 11.4 11.7 12.1 11.6
Maternal history of breast cancer (%) 5.7 5.9 6.2 5.6
Mammography regularly (%) 37.6 38.1 41.4 36.4
Age at menarche, years (mean) 13.3 13.3 13.3 13.4
Nulliparous (%) 8.4 8.5 8.2 8.2
No. of children, parous women only (mean) 2.5 2.5 2.6 2.6
Age at ﬁrst birth, parous women only, years (mean) 23.4 23.7 24.1 23.8
Postmenopausal (%) 54.2 56.5 58.3 56.6
Ever use of HRT, postmenopausal women only (%) 43.8 43.7 42.8 40.8
Ever use of oral contraceptives (%) 56.1 54.1 53.1 51.8
Energy intake, kJ/day (median) 5,911 6,368 7,011 7,392
Fat intake, g/day (median) 54 58 63 66
Alcohol intake, g/day (median) 1.5 1.5 1.6 1.2
Calcium intake, mg/day (median) 435 565 715 911
Vitamin D intake, lg/day (median) 5.6 6.2 7.2 7.7
Fruit, vegetable, and potato intake, g/day (median) 373 390 420 402
Use of cod liver oil (%) 31 39 45 47
Cancer Causes Control (2010) 21:1875–1885 1879
123drank 1–3 glasses and 0 g for women who did not drink
milk as a child.
Total dairy consumption was not associated with risk of
premenopausal or postmenopausal breast cancer either in
age-adjusted analysis or after adjusting for age, energy
intake, alcohol intake, height, weight increase since age 18,
level of physical activity, years of education, maternal
history of breast cancer, mammography practice, age at
menarche, number of children and age at ﬁrst birth, and use
of oral contraceptives (Table 3). Additional adjustment for
use of HRT among postmenopausal women reduced the
number of subjects in the model as this variable was
recorded only for women who were postmenopausal when
ﬁlling in the questionnaire (and not for those who became
postmenopausal during follow-up) and reduced the risk
estimates marginally (data not shown). Further adjustment
for BMI when ﬁlling in the questionnaire and at age 18 did
not contribute signiﬁcantly to either the pre- or the post-
menopausal model, nor did adjustment for smoking status
(data not shown). We also performed analyses adjusting for
consumption of fruit, vegetables and potatoes, total intake
of fat, and vitamin D intake; the risk estimates for pre- and
postmenopausal breast cancer changed negligible (data not
shown). Rerunning the multivariate models presented in
Table 3 after excluding women who died or got a cancer
diagnosis during their ﬁrst year of follow-up reduced the
number of premenopausal breast cancer cases to n = 121
and the number of postmenopausal breast cancer cases to
n = 733; the risk estimates were practically identical to
those given in Table 3 (data not shown).
Overall, intake of calcium tended to be inversely related
to breast cancer risk, but the risk estimates and trends were
not statistically signiﬁcant. Excluding those who died or
got a cancer diagnosis during their 1st year of follow-up
and rerunning the multivariate model in Table 3 had no
effect on the inverse trend for premenopausal breast cancer
(p for trend = 0.08), but weakened the trend for post-
menopausal breast cancer (p for trend = 0.23).
Like total dairy consumption, total milk consumption
(whole, low-fat and skimmed milk) was not associated with
neither premenopausal nor postmenopausal breast cancer
(Table 4). No noteworthy changes in risk were seen when
excluding cancer cases and deaths emerging during the 1st
year of follow-up (data not shown). When expressing total
milk consumption in terms of fat from milk (median intake
0.8 g/day) there tended to be an increasing risk for pre-
menopausal breast cancer with increasing intake of fat
from milk, whereas no association was seen for postmen-
opausal breast cancer (Table 4). Rerunning the multivariate
model in Table 4 excluding those who died or got a cancer
diagnosis during their 1st year of follow-up slightly
reduced the trend for premenopausal breast cancer (p for
trend = 0.10), otherwise there were no changes (data not
shown).
Yoghurt consumption was not associated with breast
cancer (Table 4). Consumption of white cheese showed a
Table 3 Hazard rate ratios (HRR) and 95% conﬁdence interval (CI) of invasive breast cancer according to total dairy consumption and calcium
intake. The Norwegian Women and Cancer study
Premenopausal women Postmenopausal women
Age-adjusted model Multivariate model
a Age-adjusted model Multivariate model
a
No. of
cases
(n = 218)
HRR (95% CI) No. of
cases
(n = 151)
HRR (95% CI) No. of
cases
(n = 1,189)
HRR (95% CI) No. of
cases
(n = 796)
HRR (95% CI)
Total dairy (quartiles, g/day)
\107.2 61 1.00 (ref) 45 1.00 (ref) 293 1.00 (ref) 198 1.00 (ref)
107.2–182.6 44 0.77 (0.52–1.13) 32 0.80 (0.50–1.26) 303 1.01 (0.86–1.18) 174 0.82 (0.66–1.00)
182.7–323.5 51 0.94 (0.65–1.36) 36 1.01 (0.64–1.58) 284 0.92 (0.78–1.08) 215 0.98 (0.80–1.20)
C323.6 62 1.06 (0.75–1.51) 38 1.07 (0.69–1.65) 309 1.02 (0.87–1.19) 209 1.01 (0.83–1.23)
Test for trend 0.55 0.60 0.88 0.47
Calcium (quartiles, mg/day)
\552.6 52 1.00 (ref) 42 1.00 (ref) 343 1.00 (ref) 207 1.00 (ref)
552.6–669.2 63 1.11 (0.77–1.61) 50 1.25 (0.83–1.90) 272 0.81 (0.70–0.96) 199 0.91 (0.75–1.11)
669.3–814.1 50 0.86 (0.58–1.27) 36 0.94 (0.60–1.47) 301 0.91 (0.78–1.06) 204 0.93 (0.76–1.13)
C814.2 53 0.86 (0.59–1.26) 23 0.65 (0.39–1.08) 273 0.84 (0.71–0.98) 186 0.85 (0.70–1.04)
Test for trend 0.23 0.07 0.08 0.14
a Adjusted for age, energy intake, alcohol intake, height, weight increase since age 18, level of physical activity, years of education, maternal
history of breast cancer, mammography practice, age at menarche, number of children and age at ﬁrst birth, and use of oral contraceptives
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menopausal and postmenopausal breast cancer. Premeno-
pausal women consuming at least 25 g cheese per day
(4th quartile) had a 50% reduced risk of breast cancer
compared to women consuming \6 g/day (1st quartile)
(HRR 0.50, 95% CI 0.29–0.87); for postmenopausal
women the risk was reduced by approximately 20% (HRR
0.81, 95% CI 0.66–0.99) (Table 4). The inverse associa-
tions were somewhat weakened when early cancer cases
and deaths were excluded (both: p for trend = 0.11).
Milk consumption as a child was not related to either
pre- or postmenopausal breast cancer (data not shown).
Also, when combining milk consumption as a child and
adult dairy consumption we did not observe any associa-
tion with breast cancer risk (Table 4).
As described in the ‘‘Materials and methods’’ section,
we also performed a correction for measurement error
based on the regression calibration method, on the models
presented in Tables 3 and 4, except for the analysis of
consumption as a child and as adult. The results from this
correction are given in Table 5. Notice that these analyses
are based on intake measured on continuous scale. The
general trend is that the correction does not alter the initial
ﬁndings much. The most substantial alteration takes place
in the estimated effect of white cheese, where the mea-
surement error corrected analysis shows a non-signiﬁcant
protective effect. It should be noted, however, that the
uncertainty associated with the calibration is quite large,
leading to wide conﬁdence intervals for the error corrected
estimates.
Discussion
In this prospective cohort study, we did not ﬁnd any sig-
niﬁcant association between total dairy consumption and
risk of pre- or postmenopausal breast cancer. However,
there was a tendency of an inverse association for some
Table 4 Hazard rate ratios
(HRR) and 95% conﬁdence
interval (CI) of invasive breast
cancer according to dairy food
intakes. The Norwegian Women
and Cancer study
a Adjusted for age, energy
intake, alcohol intake, height,
weight increase since age 18,
level of physical activity, years
of education, maternal history
of breast cancer, mammography
practice, age at menarche,
number of children and age at
ﬁrst birth, and use of oral
contraceptives
b The total number of cases is
reduced to 147 and 746 for pre-
and postmenopausal women,
respectively, as not all study
participants were asked about
milk consumption as a child
Premenopausal women Postmenopausal women
No. of cases
(n = 151)
HRR (95% CI)
a No. of cases
(n = 796)
HRR (95% CI)
a
Total milk (quartiles, g/day)
\49.1 38 1.00 (ref) 206 1.00 (ref)
49.1–123.9 36 1.15 (0.72–1.84) 185 0.88 (0.72–1.08)
124–269.7 40 1.37 (0.87–2.17) 195 0.89 (0.73–1.09)
C269.8 37 1.23 (0.78–1.94) 210 1.03 (0.85–1.25)
Test for trend 0.27 0.76
Fat from milk (quartiles, g/day)
\0.3 38 1.00 (ref) 188 1.00 (ref)
0.3–1.0 34 0.89 (0.54–1.48) 226 1.02 (0.82–1.27)
1.1–2.4 41 1.34 (0.83–2.16) 173 0.90 (0.72–1.13)
C2.5 38 1.39 (0.87–2.23) 209 1.12 (0.91–1.38)
Test for trend 0.06 0.48
Yoghurt (175 ml package)
Never 38 1.00 (ref) 164 1.00 (ref)
B1/week 69 0.90 (0.57–1.42) 336 0.95 (0.77–1.18)
[1 week 44 0.76 (0.47–1.24) 296 0.93 (0.75–1.15)
Test for trend 0.25 0.54
White cheese (quartiles, g/day)
\6.0 30 1.00 (ref) 208 1.00 (ref)
6.0–13.9 53 1.32 (0.86–2.02) 203 0.89 (0.73–1.08)
14.0–25.2 40 1.17 (0.73–1.87) 203 0.84 (0.68–1.02)
C25.3 19 0.50 (0.29–0.87) 182 0.81 (0.66–0.99)
Test for trend 0.02 0.03
Milk/dairy consumption as a child and as adult
b
Low 41 1.00 (ref) 165 1.00 (ref)
Moderate 83 0.75 (0.51–1.11) 486 0.91 (0.76–1.09)
High 23 1.10 (0.64–1.86) 95 1.04 (0.80–1.35)
Test for trend 0.91 0.98
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123dairy products, particularly for premenopausal breast can-
cer. Total calcium intake was inversely related to breast
cancer, whereas no association was seen for fat from milk.
Previous studies on dairy consumption and risk of breast
cancer have been inconclusive; overall there does not seem
to be a strong association either for total dairy consumption
or for speciﬁc dairy items [4, 6]. In the present study, we
saw a 50% decreased risk for premenopausal breast cancer
among women consuming 25 g of white cheese per day
compared to women consuming less than 6 g/day. How-
ever, we found no dose–response relationship. In the
analysis corrected for measurement errors an increase of
5 g cheese decreased the risk with 24%. Four previous
cohort studies [12, 19, 21, 22] and a pooled analysis of
eight cohort studies [10] did not ﬁnd any signiﬁcant asso-
ciation between cheese consumption and breast cancer risk
(pre and post), whereas in a study of Seventh-day
Adventists there was a positive trend with increasing fre-
quency of cheese consumption [15]. Also, the results from
case–control studies have been conﬂicting [4].
White cheese can be a good source for calcium. The
most used white cheeses in Norway typically contain about
800 mg calcium/100 g, and cheese contributes 28% of the
calcium intake [27]. In the present study we saw a negative
association between pre- and postmenopausal breast cancer
risk and calcium intake. Calcium intake has been inversely
related to risk of breast cancer in some prospective studies
[12, 14], although not in all [20, 24]. In two prospective
studies among US women and in a small French study,
calcium intake was inversely related to premenopausal
breast cancer, but not to postmenopausal breast cancer
[21–23]. In a Swedish prospective study, pre-diagnostic
calcium serum levels were inversely related to premeno-
pausal breast cancer in a dose–response manner, whereas a
high level of calcium indicated an increased risk among
overweight peri/postmenopausal women [45]. Further, the
Women’s Health Initiative randomized trial did not ﬁnd
any reduced incidence of breast cancer among postmeno-
pausal women who had been given calcium and vitamin D
supplementation for 7 years [46]. The possibility that any
beneﬁcial effect of calcium is modiﬁed by menopausal
status is in accordance with our ﬁnding of a somewhat
stronger association for premenopausal than for postmen-
opausal breast cancer.
Calcium may exercise its anticarcinogenic properties
through several mechanisms. In experimental studies
increased concentration of calcium decreases cell prolif-
eration and induces differentiation of mammary cells [3]. It
may bind and neutralize fatty acids and mutagenic bile
acids [6] and may also decrease fat-induced epithelial
hyperproliferation in rodent mammary glands [47]. Meta-
bolically calcium is closely related to vitamin D, which
also has been shown to inﬂuence breast carcinogenesis, and
it has been hypothesized that some of the anticarcinogenic
effect of calcium may be mediated through vitamin D [3].
For instance, calcium may play an important role in
1,25(OH)2D3 induced apoptosis [48]. In Norway, dairy
products were not fortiﬁed with vitamin D at the time of
data collection, and the correlation between calcium intake
and vitamin D intake in the present cohort was not very
strong (Pearson’s r = 0.18).
In our previous analysis of milk consumption and pre-
menopausal breast cancer, we found an inverse association
between the combined consumption of milk as a child and
as an adult and breast cancer [25]. No such association was
seen in the present study. Also, our previous analysis
showed a signiﬁcant inverse trend between milk con-
sumption as a child and breast cancer incidence restricted
to women younger than 40 years at baseline. In the present
study, the youngest women were 41 years at baseline.
Childhood dairy intake was not associated with develop-
ment of breast cancer in a 65-year follow-up of the British
Boyd Orr cohort [49], nor was childhood or adolescent
consumption of milk or dairy products consistently sig-
niﬁcantly associated with breast cancer in several studies
Table 5 Hazard rate ratios (HRR) and 95% conﬁdence interval (CI)
of invasive breast cancer according to calcium and dairy food intakes
with and without correction for measurement error. The Norwegian
Women and Cancer study
Premenopausal women
No. of cases n = 151
Postmenopausal women
No. of cases n = 796
HRR (95% CI)
a HRR (95% CI)
a
Total dairy (per 50 g)
Uncorrected 1.02 (0.97–1.07) 1.01 (0.99–1.03)
Corrected 1.02 (0.90–1.16) 0.99 (0.86–1.14)
Calcium (per 50 mg)
Uncorrected 0.96 (0.92–1.00) 0.99 (0.97–1.01)
Corrected 0.93 (0.83–1.04) 0.96 (0.84–1.10)
Total milk (per 50 g)
Uncorrected 1.04 (0.99–1.09) 1.01 (0.99–1.03)
Corrected 1.05 (0.93–1.18) 1.01 (0.88–1.15)
Fat from milk (per 0.5 g)
Uncorrected 1.03 (1.00–1.06) 1.01 (0.99–1.02)
Corrected 0.99 (0.81–1.21) 0.95 (0.82–1.09)
Yoghurt (per 10 g)
Uncorrected 0.96 (0.91–1.02) 1.00 (0.98–1.02)
Corrected 0.95 (0.86–1.05) 0.99 (0.90–1.08)
White cheese (per 5 g)
Uncorrected 0.93 (0.88–0.98) 0.99 (0.97–1.01)
Corrected 0.76 (0.53–1.09) 0.84 (0.64–1.12)
a Adjusted for age, energy intake, alcohol intake, height, weight
increase since age 18, level of physical activity, years of education,
maternal history of breast cancer, mammography practice, and use of
oral contraceptives
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123from North America [21, 50–53]. However, indications of
a negative association have been reported in two case–
control studies [54, 55].
Our ﬁnding that any weak protective effect of some
dairy products and of calcium may be stronger or limited to
premenopausal breast cancer is in accordance with previ-
ous studies [21–23]. The mechanism for this difference is
not clear. One hypothesis is that it may be due to the
decreased level of insulin growth factors with increasing
age, which interact with calcium in promoting growth
inhibition in breast cancer cells [5, 23]. Another suggestion
points to calcium’s potential as a regulator in estrogen-
driven cell proliferation [56].
The strengths of our study are the population-based and
prospective design, the large size of the cohort, the com-
plete follow-up with regard to incidence of cancer, death,
and emigration, the almost complete histological veriﬁca-
tion of breast cancer cases, and the opportunity to adjust for
all established risk factors for breast cancer. Several
questions were asked about dairy consumption and calcium
intake was calculated from about 80 semi-quantitative food
frequency questions. As dietary data are prone to mea-
surement errors we performed additional analyses cor-
recting the risk estimates for errors by using data from a
validation study performed in a subsample of the cohort
subjects [28]. As mentioned, the measurement error cor-
rections did not alter the initial ﬁndings much. This may be
taken as an indication of robustness toward effects of
measurement errors.
Possible limitations of our study should also be con-
sidered. We did not have access to repeated exposure
measures and to information on calcium supplement use,
and most non-dietary exposure variables were self-reported
for which we do not know the validity, except for meno-
pausal status and use of HRT [39].
We used the linear regression calibration method to
adjust for measurement error. This method relies on some
assumptions about the structure of possible errors in the
reference instrument (the recalls). These errors should be
random and independent of both true values and of the
errors in the questionnaire. These assumptions may or may
not be met in our case. In particular, studies have shown
that this last assumption may be doubtful [57, 58]. This
means that our method may not be able to fully correct for
measurement error. However, we believe that using this
instrument and method is our best option to at least gain
some insight into the effects of measurement error in these
studies.
In summary, in this prospective, population-based study,
we found a non-signiﬁcant inverse association between
calcium consumption and risk of breast cancer. Total dairy,
adult and childhood milk consumption was not associated
with breast cancer risk, whereas a reduced risk was seen for
women with the highest consumption of white cheese. The
results seem to be robust against effects of measurement
error. To conﬁrm any potential protective effect of calcium
and/or speciﬁc dairy products, more well-designed pro-
spective studies are needed. The protective potential may
be largest for premenopausal breast cancer.
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